Cherry blossoms in falling market: 10 Stocks to buy for 16-64% profit
Sat, Aug 31, 2013 at 15:59
Target: Rs 893
Potential Upside: 16%
Rationale: As the company has the richest pipeline of products and filings as compared with the other Pharma companies, the stock looks appealing. Meanwhile the consistent product launches and increasing its access to other countries like Japan, which is the world's second largest Pharmaceutical market, is likely to depict the growth story of the company. However, the New Drug Price Control Order in India may stand as a hurdle to the company.